NCT06710418View on ClinicalTrials.gov

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 14, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Acute Myeloid LeukemiaB Acute Lymphoblastic LeukemiaB Lymphoblastic LymphomaMyeloid Neoplasm
Interventions
OTHER

Activity Tracking

Ancillary studies

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

PROCEDURE

Cognitive Assessment

Ancillary studies

OTHER

Electronic Health Record Review

Ancillary studies

OTHER

Packed Red Blood Cell Transfusion

Undergo PRBC transfusion

OTHER

Quality-of-Life Assessment

Ancillary studies

Trial Locations (1)

98109

RECRUITING

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT06710418 - Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia | Biotech Hunter | Biotech Hunter